[Rupture of esophageal varices].
Vinel
Jean-Pierre
JP
Hépato-Gastroentérologie, Fédération Digestive, CHU Purpan INSERM U531, 31059 Toulouse. vinel.jp@chu-toulouse.fr
D018849:Controlled Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004932:Esophageal and Gastric Varices / Q000150:complications* / Q000601:surgery; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000209:etiology* / Q000628:therapy*; D016558:Hemostasis, Endoscopic; D006490:Hemostatics / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006975:Hypertension, Portal / Q000601:surgery; D008026:Ligation; D008103:Liver Cirrhosis / Q000150:complications; D008236:Lypressin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D005996:Nitroglycerin / Q000008:administration & dosage / Q000627:therapeutic use; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use; D011170:Portasystemic Shunt, Surgical; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D017410:Practice Guidelines as Topic; D012008:Recurrence; D012421:Rupture; D015911:Sclerotherapy; D013004:Somatostatin / Q000008:administration & dosage / Q000627:therapeutic use; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014667:Vasopressins / Q000008:administration & dosage / Q000627:therapeutic use
D005765:Gastrointestinal Agents; D006490:Hemostatics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014667:Vasopressins; D008236:Lypressin; D013004:Somatostatin; D000077585:Terlipressin; D005996:Nitroglycerin; D015282:Octreotide